A study of patients with metastatic lung cancer by researchers based in Brazil and the United States has found that their ...

Municipalities in Newfoundland and Labrador are taking action against radon, an invisible radioactive gas that causes lung ...

A new blood test which could help thousands of people receive ... which accounts for at least 80 per cent of lung cancer cases – that can be taken at home by patients, Professor Popat said: “These ...

More doctors are ordering bioAffinity Technologies' CyPath Lung test and sales are skyrocketing. A long-term military health ...

A 5-second finger test may help detect early lung cancer signs. By analyzing finger patterns, one can identify finger clubbing, an indicator in over 35% of non-small cell lung cancer cases.

Affinity Technologies' CyPath® Lung test will be added to the Federal Supply Schedule to help veterans and active military at ...

SAN ANTONIO, October 16, 2024--bioAffinity VP served on expert panel to update flow cytometry guidelines for unique ...

SAN ANTONIO, Texas--(BUSINESS WIRE)--A new economic study found that adding CyPath® Lung, bioAffinity Technologies’ noninvasive test for detection of early-stage lung cancer, to the standard of ...

UK-based Cizzle Biotechnology signed the licensing agreement with its US-based partner, Cizzle Bio, for the commercialization of early cancer detection tests.

Cizzle Biotechnology Holdings plc (Cizzle), the UK based diagnostics developer, is pleased to announce that it has signed an exclusive licensing agreement with Cizzle Bio granting exclusive rights to ...

“Our CyPath® Lung noninvasive test for the early detection of lung cancer is a novel test that uses sputum, a unique sample type that is not typically used in clinical flow cytometry assays ...

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced that CyPath® Lung ...